Abstract The X-ray repair cross-complementation group 1 (XRCC1) gene plays an important role in base excision repair pathway. Several studies have reported contradictory results for XRCC1 exon 10 (Arg399Gln, G23990A, rs25487) gene polymorphism and cancer risk in Indian population, making it difficult to interpret them. Therefore, we have conducted a meta-analysis to evaluate the more precise association between XRCC1 exon 10 G[A gene polymorphism and risk of cancer by published studies. We searched PubMed (Medline) and Google scholar web databases to cover all studies published on association between XRCC1 exon 10 G[A gene polymorphism and cancer risk until August 2016. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to appraise the strength of association. Heterogeneity, publication bias and sensitivity analysis were also assessed. Twenty-five published studies had fulfilled the inclusion criteria comprising 4131 confirmed cancer cases and 5013 controls. When all studies were polled together, overall significant association was found between XRCC1 exon 10 G[A polymorphism and cancer risk in variant allele carrier (A vs. G: OR 1.217, 95% CI 1.056-1.402, p = 0.007), homozygous (AA vs. GG: OR 1.359, 95% CI 1.036-1.783, p = 0.027), dominant (AA?AG vs. GG OR 1.208, 95% CI 1.006-1.450, p = 0.043) and recessive (AA vs. AG?GG: OR 1.315, 95% CI 1.029-1.680, p = 0.029) genetic models. Further sensitivity analysis supported the stability of our result by showing similar ORs before and after removal of a single study. The present meta-analysis suggested that the XRCC1 exon 10 G[A polymorphism contribute cancer risk in Indian population, and supports that individuals with risk allele A and AA genotype are at higher risk of developing cancer.
Introduction
Cancer remains a major health problem leading to increased morbidity and mortality around the world [1] . The issue is major concern especially in developing country like India, where cancer incidence is predicted to reach 1148,757 cases in the year 2020 [2] . The precise mechanism of carcinogenesis is still complicated and largely unknown. Epidemiological studies reported that interaction between genetic and environmental factors play an important role in cancer development [3] .
Recent genome-wide association studies (GWAS) have clearly unveiled that single-nucleotide polymorphisms (SNPs) is the most common forms of human genetic variation have important role in defining individual susceptibility to cancer [4] . This clearly indicated that SNPs can be used as promising biomarker in the near future for the assessment of individual genetic background for cancer prognosis and signify an interesting field of cancer research. Knowledge of cancer genetics is rapidly improving and helping us to identify individuals at risk and provide new possibilities for the diagnosis and treatment of cancer.
Human genome is constantly damaged by endogenous and exogenous sources, and the repair of damaged DNA is essential to protect cells against cancer [5] . Different DNA repair pathways and genes system have evolved to repair the specific type of DNA lesion and maintain the genomic integrity. SNPs in DNA repair genes may influence DNA repair capacity and can lead to genomic instability and modulation of cancer susceptibility [6] .
Base damage and DNA single strand breaks are repaired through the base excision repair (BER) pathway. Xray Repair Cross Complementing Group 1 (XRCC1, located on chromosome 19q13.2), is a DNA repair protein mainly repair DNA damage caused by active oxygen, ionization and alkylating agents [7] . XRCC1 acts as a scaffolding protein with DNA polymerase b via the NH2 terminus domain and with DNA ligase III BRCT domain in detection and protection of DNA strand breaks and subsequent targeting of BER complex to the damaged site [8] . Several polymorphism have been identified in XRCC1 gene, among them codon 399 (Arg to Gln substitution, G23990A, rs25487) is located in the non conserved region between conserved residues of the BRCT-I interaction domain. Variant allele 399Gln demonstrated association with higher levels of mutation, reduced DNA repair capacity and prolonged cell cycle delay thereby influence susceptibility to cancer [9] .
Considering their significant role of XRCC1 gene in DNA repair and mutation, numerous epidemiological case-control studies have been performed to evaluate the association between the XRCC1 exon 10 G[A gene polymorphism and cancer susceptibility in Indian populations, but the results have been inconclusive .
Researchers of the reported studies have not yet come up with a concrete agreement, because up to now, there has been no comprehensive research conducted to combine the data of various cancer studies. However, they have shown the XRCC1 polymorphism have role in different types of cancer in Indian population, but single study is always underpowered to reflect the reliable results. Therefore, we conducted this meta-analysis with rigorous statistical method to derive the more precise results of the association between XRCC1 exon 10 G[A gene polymorphism and overall cancer risk among Indian population.
Materials and Methods

Literature Search Strategy
A systematic literature search was conducted on PubMed (Medline) and Google scholar to identify studies that had investigated the association of XRCC1 gene polymorphisms and cancer risk in Indian population, last updated searched was performed on August 2016. The search key were used XRCC1 OR X-ray repair cross complementing group 1 and ''polymorphism OR mutation OR variant'' and ''Cancer OR malignancy OR tumor'' and ''Indian OR India''. The search was focused on studies that had been carried out in humans. We also did manual search of reference list from the retrieve articles for other additional eligible studies. 
Inclusion and Exclusion Criteria
Articles included in the current meta-analysis had to meet all the following criteria: (1) must evaluated the association between XRCC1 exon 10 polymorphism and cancer risk, (2) use a case-control design, (3) recruited histologically confirmed cancer patients and healthy controls, (4) have available genotype frequency in case and control. In addition, the following exclusion criteria were also used: (1) repeated or overlapping studies, (2) case only studies, (3) review articles, (4) animal studies, (5) no usable data reported.
Data Extraction and Quality Assessment
To minimize the bias and improve the reliability, the methodological quality assessment and data extraction were independently abstracted by two independent researchers by strictly following the inclusion-exclusion criteria mentioned above. The major characteristics abstracted from the retrieved studies included the name of the first author, year of publication, the number of cases and controls, type of cancer, genotype frequencies for cases and controls and source of genotyping. An agreement was reached by fully discussion between the two researchers whenever there was a conflict.
Statistical Analysis
The strength of the association between XRCC1 exon 10 G[A polymorphism and cancer risk was measured by their corresponding 95% CIs and ORs. Heterogeneity assumption between studies was performed by the Chi square based Q-test and considered significant at p value \ 0.05 [35] . A fixed effect model (if p [ 0.05) OR a random effect model (if p \ 0.05) was used for pooling the results [36, 37] . Moreover, I 2 statistics was also employed to efficiently test the heterogeneity. Hardy-Weinberg equilibrium (HWE) in the controls was measured via Chi square test. Funnel plot asymmetry was estimated by Egger's linear regression test which is a type of linear regression approach to estimate the funnel plot asymmetry 
Results
Literature Search and Meta-Analysis Databases
We identified a total of fifty-two studies by scrupulous literature search from the PubMed (Medline) and Google scholar. As per the pre-set selection (inclusion-exclusion) criteria, a total of twenty-five research articles were finally included (Fig. 1) . Studies showing XRCC1 polymorphism to predict survival OR as an indicator for response to therapy of patients were excluded straightaway. Similarly, research articles investigating the levels of XRCC1 mRNA or protein expression and relevant review articles were also excluded. We included only case-control or cohort design studies having frequency of all three genotypes. Eligible included studies, cancer types, publication year, distribution of genotypes and minor allele frequency (MAF) in the controls and cases have been shown in Tables 1 and 2 . 
Publication Bias
The Begg's funnel plot and Egger's test were performed to examine the publication bias among the included studies for this meta-analysis. The shape of funnel plot did not elucidate any asymmetry in all comparison models. Egger's test, a linear regression approach for measuring funnel plot on the natural logarithm scale of the OR, also showed no evidence of publication bias ( Table 3) .
Evaluation of Heterogeneity
In order to test heterogeneity among the selected studies, Q-test and I 2 statistics were employed. Heterogeneity was observed in all genetic models, i.e. allele (A vs. G), homozygous (AA vs. GG), heterozygous (AG vs. GG), dominant (AA?AG vs. GG) and recessive (AA vs. AG?GG). Thus, random effect model was applied to synthesize the data for above models (Table 3) .
Overall Association of XRCC1 Exon 10 G>A Polymorphism and Cancer
We pooled all twenty-five studies together and it resulted into 4131 confirmed cancer cases and 5013 healthy controls to examining the overall association between XRCC1 exon 10 G[A gene polymorphism and cancer risk. The pooled OR from all eligible studies indicated significant risk of cancer susceptibility with variant allele (A vs. G: OR 1.217, 95% CI 1.056-1.402, p = 0.007), homozygous (AA vs. GG: OR 1.359, 95% CI 1.036-1.783, p = 0.027), dominant (AA?AG vs. GG OR 1.208, 95% CI 1.006-1.450, p = 0.043) and recessive (AA vs. AG?GG: OR 1.315, 95% CI 1.029-1.680, p = 0.029) genetic models compared with wild type GG genotype. Whereas, no significant association was found in heterozygous (AG vs. GG: OR 1.135, 95% CI 0.942-1.368, p = 0.183) model (Figs. 2, 3, 4, 5and 6 ).
Sensitivity Analysis
We have performed sensitivity analysis by sequentially omitting individual study to evaluate the stability of the present meta-analysis. The results of sensitivity analysis indicated that pooled OR before and after exclusion of the study which probably contribute the heterogeneity were generally similar. Hence, the results of this meta-analysis were stable and convincing (Figures not shown) .
Trial Sequence Analysis (TSA) of XRCC1 Exon 10 G>A Polymorphism and Cancer
The results of TSA were consistent with present meta-analysis. TSA analysis used allele genetic model (A vs. G) revealed that cumulative Z curve crossed with TSA monitoring boundary before reaching the required information size, confirmed that this polymorphism is associated with increased risk and further relevant trials are unnecessary (Fig. 7) .
Discussion
DNA repair mechanisms play an important role in protection against damage and mutation. Genetic polymorphism in DNA repair genes may be the underlying molecular mechanism of the individual variation in DNA repair capacity. Several studies have supported an important role for genetics in determining the risk for cancer, and association studies are apposite for searching susceptibility genes involved in cancer [42] . Hence, it is more reasonable to identify the key gene polymorphisms that are associated with cancer risk is essential for predicting individual at risk. The XRCC1 protein has shown the importance of early development in mouse models, presumably for repair of endogenous DNA [43] . XRCC1 interacts with poly (ADPribose) polymerase, a nuclear zinc-finger DNA-binding protein that detects single strand breaks and polynucleotide kinase and thereby accelerates the overall repair process. This novel pathway for mammalian single-strand break repair reveals a concerted role for XRCC1 gene in the initial step of processing damaged DNA ends [44] .
In the present meta-analysis, our main focus was to estimate the more precise results to understand the contribution of XRCC1 exon 10 G[A gene polymorphism in overall cancer susceptibility. Meta-analysis is a powerful statistical tool for deriving results from pooled data because it combines the data from individual studies where individual sample sizes are small and lower statistical power and resolve discrepancy in genetic association studies [45] . Currently, it is broadly cited and accepted as the highest level of evidence in epidemiological studies and medical science. To our knowledge, this is the first meta-analysis to assess the relationship between XRCC1 exon 10 G[A gene polymorphism and overall cancer risk among Indian population. The associations for the allele contrast, homozygous, heterozygous, dominant and recessive models were examined. After rigorous statistical analysis, we found that A allele and homozygous AA genotype of XRCC1 gene was associated with a significant increased risk of cancer susceptibility in all four genetic models. Our meta-analysis serves as a preliminary overview of the involvement of XRCC1 exon 10 G[A gene polymorphism as a potential etiological factor in carcinogenesis and sheds some light on the pathogenesis of its deadly disease. The codon 399 G[A polymorphism could influence the function of XRCC1 gene and may influence DNA repair capacity and consequently increase the risk of developing cancer. Experimental evidence suggested that 399Gln allele have higher number of chromosomal breaks, DNA adducts per cell than those with other genotypes, and these type of subjects are more prone to chemically induced genetic damage [46] . Cells lacking the XRCC1 protein are hypersensitive to damage from ionizing radiation and alkylating agents and that XRCC1 is required for the efficient repair of single strand DNA damage [47] .
Genetically complex diseases differ from simple Mendelian diseases and cancer etiology is polygenic, a single genetic variant is usually inadequate to predict the risk of this deadly disease. Though, we interpreted our findings with full caution, but, some limitation of our meta-analysis should be addressed. Heterogeneity is an important issue while interpreting the results of meta-analysis, although, it can be minimized by applying random-effects model (45) . In the present study we detected inter-study heterogeneity. The source of heterogeneity may arise possibly due to regional lifestyle varied among populations from different parts of India [48] , another point could be recruitment of control subjects. Gene environment interaction and adjusted ORs have not been performed due to the limited number of data.
In spite of this, the current study has some advantages. First, this meta-analysis involved large set of individual data from twenty-five independent studies, which provide enough statistical power to authenticate our results. Second, publication bias was not found by funnel plot and Egger linear regression test, thus the all results are statistically robust. Third, Sensitivity analysis showed that the results were not influenced by any single study. Fourth, TSA also showed that the conclusions are robust. Moreover, we used explicit criteria for present study's inclusion and performed strict data extraction and analysis to make satisfactory and robust conclusion.
Conclusion
In summary, our meta-analysis indicated that the variant allele and genotypes of XRCC1 exon 10 G[A gene polymorphism was associated with a cancer risk in Indian population. This finding may useful for screening high risk individual for primary preventing and early detection as treatment of cancer for both researchers and clinicians. Further, more intensive and deeper studies will be required to understand the effect of XRCC1 gene polymorphisms on cancer risk in Indian population.
